Navigation Links
ACE, the Accreditation for Cardiovascular Excellence, Cited as Effective Program for Restoring Hospital Reputation
Date:3/18/2013

ting risk for all stakeholders,” said Ms. Schroeder. With public reporting becoming more widespread and reimbursement models increasingly tied to this data, Ms. Schroeder notes that a “…lack of complete data and transparency continue to affect CCL performance” and that “…peer review should not be reserved for poor outcomes situations.”

ACE offers Accreditation and E3 More Than Peer Review services for validating Cath/PCI processes in the CCL. ACE programs deliver confidence by utilizing cardiology specialists to guide the development of an integrated quality program. Through objective evaluation, validating and team-building, ACE partners with your organization to ensure the quality outcomes process. The effectiveness of ACE services is recognized in a recent press statement: “Much has changed over the past year,” said Robert Rogalski, chief executive officer of Excela. “In fact, Excela Health has achieved national recognition for quality standards within our CCL, emphasizing our focus on patient safety.” Visit the ACE website for additional information and to schedule a complementary one-hour consultation: http://www.cvexcel.org.

About Accreditation for Cardiovascular Excellence

ACE, an independent organization sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology Foundation (ACCF), offers independent evaluation and monitoring of facilities that provide cardiovascular care. By reviewing facility and operator performance and comparing clinical decision-making to nationally accepted best practices, ACE peer review and accreditation services plays a critical role in continuous quality improvement programs. Learn more at http://www.cvexcel.org.

_____________________________
i Gormley, J. Cardiovascular Business Ill Repute: Mainta
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Beta Testing Opportunity for URAC Clinically Integrated Network Accreditation Program
2. IASLC awarded accreditation as continuing medical education provider
3. AIUM and AUA guideline development leads to practice accreditation for urologic ultrasound
4. NYUCNs Dr. Laura Wagner: Study finds accreditation improves safety culture at nursing homes
5. Delgado Protocol Announces Adrenal DMG, An Amazing New Supplement Designed to Support the Immune, Circulatory and Cardiovascular Systems
6. Los Angeles Periodontist, Dr. Markzar, is Now Informing Patients about the Possible Connection between Gum Disease and Cardiovascular Disease
7. Tooth loss associated with cardiovascular risk factors in patients with chronic heart disease
8. ViVitro Labs Adds Real-Time Wear Tester to Their Line of Cardiovascular Device Testing Equipment
9. Cardiovascular risk may remain for treated Cushings disease patients
10. Mainz University Medical Center receives further DFG funding for cardiovascular research
11. The worlds premier cardiovascular congress goes to Amsterdam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... pm EDT): In a Viewpoint published today in the ... team of Boston researchers call for the implementation of ... United States. The researchers from the Friedman School of ... and Boston Children,s Hospital write that policies taxing nearly ... help people make meaningful dietary changes and substantially reduce ...
(Date:9/2/2014)... TCG, a leading government technology strategy and IT consultancy, ... fastest-growing companies in America for the seventh year in a ... in 2013, 2012, 2011, 2010, 2009, 2008, and the Inc. ... 2010 to 2013, ranking the company at position 3,708 on ... up 635 spots from 2013! More information is on ...
(Date:9/2/2014)... The use of Xarelto (known generically ... at a rapid pace, even as Xarelto lawsuits ... the U.S., Bernstein Liebhard LLP reports. According to a ... a year of its 2011 launch, patients were just ... blood thinner that has been in use for several ...
(Date:9/2/2014)... News) -- Complications are rare among breast cancer ... study indicates. However, the researchers did find ... slightly higher risk for certain complications than a ... 18,000 breast cancer patients who had a single ... reconstruction and were followed for 30 days after ...
(Date:9/2/2014)... September 2, 2014 In a large population-based ... found that mild cognitive impairment (MCI) occurred twice ... type 2. Interestingly, this strong association was only ... older participants (66-80 years) the association vanished. This ... Alzheimer,s Disease . , The concept of MCI ...
Breaking Medicine News(10 mins):Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2Health News:Diabetes mellitus and mild cognitive impairment: Higher risk in middle age? 2
... very practical agents in therapeutic applications. Researchers from ... Institute of Technology, writing Cancer Letters // (Available ... nanospheres as photothermal agent by selectively delivering gold ... a clinically related cancer biomarker, and discuss the ...
... true for the scientists who been working hard for the ... take an extra step ahead as it is likely to ... as their offspring, are safe to eat., ,Canada ... Canadian Scientists having proved themselves following the success regarding Starbuck, ...
... Publication, released on the 5th of October, which comprises ... has a comprehensive report on the threat of chronic ... Union Health Minister Dr Anbumani Ramadoss, the need to ... of chronic diseases in India was highlighted, stating that ...
... Sanofi Pasteur and Merck and found to be effective ... doses over 6 months which has shown 100% successful. The company ... protects against Human Papilloma virus infection and also genital warts, which ... market early next year and the profits would be great, and ...
... to regularly floss your teeth or so your dentist tells ... larger percentage of the population does not indulge in flossing. ... leads to gum problems including bleeding gums, receding gums and ... American Dental Association's (ADA) annual conference in Philadelphia says that ...
... for breast cancer patients, who show positive for Her-2/neu. ... positive, and they have a more resistant and active ... are Her-2/neu positive and the treatment for these patients ... not show any significant disease reduction. These patients should ...
Cached Medicine News:Health News:Gold Nanoparticles: Agents For Noninvasive Cancer Therapy 2Health News:Strategies to prevent the rising tide of the epidemic of chronic diseases 2Health News:Gardasil vaccine for cervical cancer 2
(Date:9/2/2014)... According to the new market research report ... Material (Metal, Glass, Plastic), by Application [GC, LC (HPLC, ... by MarketsandMarkets, the Chiral Chromatography Columns Market was valued ... at a CAGR of 5.2% from 2013 to reach ... market data tables and 15 figures spread through 135 ...
(Date:9/2/2014)... 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) ... the company at the Morgan Stanley Global Healthcare Conference in ... date: Tuesday September 9, 2014 , Presentation time: 5:15 ... 30-day archive of this presentation will be available at ... Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on ...
(Date:9/2/2014)... 2014  EMD Serono, Inc., a subsidiary of Merck ... that Drew Young has joined the company ... capacity, he will be responsible for leading the strategic ... future products.   Bringing more than 20 years ... efforts at pharmaceutical and biotech companies, Mr. Young comes ...
Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4
... that a new market research report is available in ... Drug Delivery System http://www.reportlinker.com/p0337136/Chinese-Markets-for--Drug-Delivery-System.html ... System has grown at a fast pace in the ... and demand will continue to grow. This new study ...
... 9, 2010 Reportlinker.com announces that ... catalogue: Prostate Cancer - Italy Drug ... http://www.reportlinker.com/p0332355/Prostate-Cancer---Italy-Drug-Forecasts-and-Treatment-Analysis-to-2020.html Prostate Cancer - Italy ... SummaryGlobalData,s pharmaceutical report, "Prostate Cancer - Italy Drug ...
Cached Medicine Technology:Reportlinker Adds Chinese Markets for Drug Delivery System 2Reportlinker Adds Chinese Markets for Drug Delivery System 3Reportlinker Adds Chinese Markets for Drug Delivery System 4Reportlinker Adds Chinese Markets for Drug Delivery System 5Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 2Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 3Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 4Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 5Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 6Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 7Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 8Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 9Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 10Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 11Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 12Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 13Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 14
Two prong stainless steel tips; with titanium handle/...
Straight shafts with fine Pierse type tips on a 5mm platform; In Titanium...
Smooth colibri tip; In Titanium....
Gently curved 5mm Platform With 12, 0.12mm Teeth; In Titanium....
Medicine Products: